Back
  1. Home
  2. Profile of Solène Dauby (ULiège)
Profil

Dauby Solène

GIGA Neurosciences - Clinical Neurology

Département des sciences cliniques > GIGA

Neurologie

See author's contact details
ORCID
0000-0002-5153-8367
Main Referenced Co-authors
Maquet, Pierre  (8)
Lommers, Emilie  (6)
Dive, Dominique  (5)
Hansen, Isabelle  (3)
Phillips, Christophe  (3)
Main Referenced Keywords
multiple sclerosis (3); Humans (2); longitudinal analysis (2); Medicine (all) (2); Multiple Sclerosis/therapy (2);
Main Referenced Unit & Research Centers
GIGA CRC In vivo Imaging-Neuroimaging, data acquisition and processing - ULiège (1)
Main Referenced Disciplines
Neurology (12)
Engineering, computing & technology: Multidisciplinary, general & others (2)
Immunology & infectious disease (2)
Laboratory medicine & medical technology (1)
Radiology, nuclear medicine & imaging (1)

Publications (total 14)

The most downloaded
658 downloads
Dive, D., Dauby, S., Lommers, E., Hansen, I., Groenendyck, D., ERNON, C., & Maquet, P. (May 2022). La sclérose en plaques : une maladie neurologique dysimmunitaire inflammatoire. Revue Médicale de Liège, 77 (5-6), 384-391. https://hdl.handle.net/2268/296686

The most cited

24 citations (OpenAlex)

Dauby, S., DIVE, D., LUTTERI, L., ANDRIS, C., HANSEN, I., MAQUET, P., & LOMMERS, E. (2022). Comparative study of AQP4‑NMOSD, MOGAD and seronegative NMOSD: a single‑center Belgian cohort. Acta Neurologica Belgica. doi:10.1007/s13760-021-01712-3 https://hdl.handle.net/2268/262215

Dauby, S. (2024). Cortex pathology in MS patients & research in Liège [Paper presentation]. Positioning of Mavenclad in MS disease course, Liège, Belgium.

Dauby, S. (07 March 2024). Y voir plus clair sur la prise en charge des névrites optiques ? [Paper presentation]. ParadigMS Ninth Belgian Symposium.

Dauby, S. (28 October 2023). Communications by Young Researchers: MS cortical lesions [Paper presentation]. Belgian MS Symposium.

Dauby, S. (April 2023). BIOLOGIE CLINIQUE ET PATHOLOGIES NEURO-INFLAMMATOIRES DU SNC [Paper presentation]. Glem de Biologie clinique.

Vandeleene, N., Guillemin, C., Dauby, S., Requier, F., Charonitis, M., Chylinski, D., Balteau, E., Maquet, P., Lommers, E.* , & Phillips, C.*. (2023). Using quantitative magnetic resonance imaging to track cerebral alterations in multiple sclerosis brain: A longitudinal study. Brain and Behavior. doi:10.1002/brb3.2923
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Moallemian, S., Dauby, S., Meyer, F., Bastin, C., Phillips, C., Salmon, E., Maquet, P., Bonhomme, V., Dammicco, S., Degueldre, C., Laleux, S., Beliy, N., & Bahri, M. A. (2023). PET Pro: An Automated pipeline to estimate the image-derived input function for UCB-H PET [Paper presentation]. INCF 2023.
Peer reviewed

Dive, D., Dauby, S., Lommers, E., Hansen, I., Groenendyck, D., ERNON, C., & Maquet, P. (May 2022). La sclérose en plaques : une maladie neurologique dysimmunitaire inflammatoire. Revue Médicale de Liège, 77 (5-6), 384-391.
Editorial Reviewed verified by ORBi

Lambert, N., Dauby, S., DIVE, D., SADZOT, B., & MAQUET, P. (January 2022). Atezolizumab Treatment for Progressive Multifocal Leukoencephalopathy. Emerging Infectious Diseases, 28 (1). doi:10.3201/eid2801.204809
Peer Reviewed verified by ORBi

Dauby, S., DIVE, D., LUTTERI, L., ANDRIS, C., HANSEN, I., MAQUET, P., & LOMMERS, E. (2022). Comparative study of AQP4‑NMOSD, MOGAD and seronegative NMOSD: a single‑center Belgian cohort. Acta Neurologica Belgica. doi:10.1007/s13760-021-01712-3
Peer Reviewed verified by ORBi

Dauby, S., & Lommers, E. (2022). Datablitz 2022 : Multimodal quantification of brain microstructure and synaptic density in multiple sclerosis patients [Paper presentation]. Datablitz : Quand la clinique rencontre la recherche fondamentale.

Vandeleene, N., Guillemin, C., Dauby, S., Requier, F., Charonitis, M., Chylinski, D., Balteau, E., MAQUET, P., LOMMERS, E.* , & Phillips, C.*. (2022). Using quantitative MRI to track cerebral damage in multiple sclerosis: a longitudinal study. (Preprint). ORBi-University of Liège. https://orbi.uliege.be/handle/2268/289020. doi:10.1101/2022.01.26.22269806
* These authors have contributed equally to this work.

Lambert, N., El Moussaoui, M., Steinmetz, M., Dauby, S., DIVE, D., SADZOT, B., & MAQUET, P. (19 June 2021). Anti-PD-L1 Treatment for Progressive Multifocal Leukoencephalopathy: Lessons from Two Cases [Paper presentation]. 7th Congress of the European Academy of Neurology.

Dive, D., Dauby, S., Lommers, E., Hansen, I., & Maquet, P. (May 2020). Actualités thérapeutiques dans la sclérose en plaques. Revue Médicale de Liège, 75 (5-6), 382 - 385.
Editorial Reviewed verified by ORBi

Bos, I., Vos, S., Frölich, L., Kornhuber, J., Wiltfang, J., Maier, W., Peters, O., Rüther, E., Engelborghs, S., Niemantsverdriet, E., De Roeck, E., Tsolaki, M., Freund-Levi, Y., Johannsen, P., Vandenberghe, R., Lleo, A., Alcolea, D., Frisoni, G., Galluzzi, S., ... Visser, P. (2016). Prevalence of vasculare risk factors in different stages of prodromal Alzheimer’s disease and its influence on cognitive decline. Alzheimer's and Dementia: the Journal of the Alzheimer's Association, 12 (7), 1059-1061. doi:10.1016/j.jalz.2016.06.2213
Peer Reviewed verified by ORBi

Contact ORBi